J Korean Med Sci.  2012 Jan;27(1):84-88. 10.3346/jkms.2012.27.1.84.

Ischemic Stroke in Rats Enhances Bone Resorption in Vitro

• Chung ME
• Lee JI
• Im S
• Park JH

• KMID: 1792984
• DOI: http://doi.org/10.3346/jkms.2012.27.1.84

Abstract

We hypothesized that the formation and differentialtion of osteoclasts are accelerated and the potential of bone resorption is increased in the hemiplegic bone marrow in the early stage of stroke. We randomly divided white female Sprague-Dawley (SD) rats (n = 30) into two groups, stroke (n = 15) and sham group (n = 15). On the 7th day after stroke, after cutting away the epiphyses of the femurs and tibias, diaphyseal channels were flushed using alpha-minimum essential medium (alpha-MEM) and bone marrow cells were collected. Bone marrow stem cells, which were extracted from the femur and tibia, were cultured on the 7th day after middle cerebral artery occlusion. We then estimated the ratio of non-adherent cells to total bone marrow cells that included osteoclast precursor cells. After culturing these cells separately, cells that tested positive on the tartrate resistant acid phosphatase (TRAP) were counted and bone resorption was evaluated by using the OAAS(TM) plate. In comparison to the control group, the stroke group showed a higher increase of non-adherent cells in the hemiplegic side bone marrow. In addition, after the primary culture, the stroke group showed an increased number of TRAP positive cells and a higher degree of bone resorption estimated by OAAS(TM) plate. As a result, osteoclastogenesis and osteoclast differentiation are accelerated and the potential of bone resorption is increased in the hemiplegic bone marrow and these changes are detected as early as within the first week after middle cerebral artery occlusion in SD rats.

Keyword

Bone Resorption; Osteoclasts; Osteoporosis; Stroke

MeSH Terms

Animals
Bone Marrow Cells/cytology/drug effects
Bone Resorption/*physiopathology
Cell Differentiation
Cell Separation
Cells, Cultured
Female
Femur/cytology
Osteoclasts/cytology
Rats
Rats, Sprague-Dawley
Stem Cells/cytology/metabolism
Stroke/*metabolism/pathology
Tartrates/pharmacology
Tibia/cytology

Figure

• 

  Fig. 1 Percentage of non-adherent cells from bone marrow. CTR, controls; S-HS, hemiplegic side of the stroke group; S-NHS, non-hemiplegic side of the stroke group. Data are the mean ± SEM. *P < 0.05 control.

• 

  Fig. 2 Tartrate resistant acid phosphatase (TRAP) positive cells from bone marrow. CTR, controls; S-HS, hemiplegic side of the stroke group; S-NHS, non-hemiplegic side of the stroke group. Data are the mean ± SEM. *P < 0.05 control.

• 

  Fig. 3 Photomicrographs of osteoclasts in primary culture obtained from bone marrow of rats, TRAP stain, magnification ×100. (A) Control. (B) Hemiplegic side of the stroke rats. (C) Non-hemiplegic side of the stroke rats.

• 

  Fig. 4 The percentage of mineral surface resorbed by osteoclasts on OAAS™ plate. CTR, controls; S-HS, hemiplegic side of the stroke group; S-NHS, non-hemiplegic side of the stroke group. Data are the mean ± SEM. *P < 0.05 control.

• 

  Fig. 5 Photomicrographs of pits formed by osteoclasts from rats, magnification ×25. (A) Control. (B) Hemiplegic side of the stroke group. (C) Non-hemiplegic side of the stroke group.

Reference

1. Kanis JA, Glüer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int. 2000. 11:192–202.

2. Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ 3rd. Direct medical costs attributable to osteoporotic fractures. Osteoporos Int. 2002. 13:323–330.

3. Ramnemark A, Nilsson M, Borssén B, Gustafson Y. Stroke, a major and increasing risk factor for femoral neck fracture. Stroke. 2000. 31:1572–1577.

4. Ramnemark A, Nyberg L, Lorentzon R, Englund U, Gustafson Y. Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke. Osteoporos Int. 1999. 9:269–275.

5. Choi EK. The effects of decreased physical activity to bone mineral density in hemiparetic stroke patients. Korean J Med. 2005. 69:387–394.

6. Sato Y, Kuno H, Kaji M, Etoh K, Oizumi K. Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke. J Neurol Sci. 2000. 175:135–139.

7. Sato Y, Maruoka H, Oizumi K, Kikuyama M. Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. Stroke. 1996. 27:2183–2187.

8. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989. 20:84–91.

9. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995. 26:627–634.

10. Mehta SH, Dhandapani KM, De Sevilla LM, Webb RC, Mahesh VB, Brann DW. Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology. 2003. 77:44–50.

11. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003. 423:337–342.

12. Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol. 2007. 143:31–48.

13. Jones D, Glimcher LH, Aliprantis AO. Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection. J Clin Invest. 2011. 121:2534–2542.

14. Grano M, Mori G, Minielli V, Barou O, Colucci S, Giannelli G, Alexander C, Zallone AZ, Vico L. Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex vivo cultures. Calcif Tissue Int. 2002. 70:176–185.

15. Sato Y, Fujimatsu Y, Kikuyama M, Kaji M, Oizumic K. Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. J Neurol Sci. 1998. 156:205–210.

16. Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest. 1990. 85:456–461.

17. Poole KE, Vedi S, Debiram I, Rose C, Power J, Loveridge N, Warburton EA, Reeve J, Compston J. Bone structure and remodeling in stroke patients: early effects of zoledronate. Bone. 2009. 44:629–633.

18. Sato Y, Iwamoto J, Honda Y. Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke. J Stroke Cerebrovasc Dis. 2010. 19:198–203.